Search alternatives:
significantly smaller » significantly larger (Expand Search), significantly shorter (Expand Search), significantly higher (Expand Search)
significant degs » significant genes (Expand Search), significant adverse (Expand Search), significant cause (Expand Search)
smaller decrease » small decrease (Expand Search), marked decrease (Expand Search), smaller areas (Expand Search)
degs increased » drugs increased (Expand Search), bems increased (Expand Search), days increased (Expand Search)
significantly smaller » significantly larger (Expand Search), significantly shorter (Expand Search), significantly higher (Expand Search)
significant degs » significant genes (Expand Search), significant adverse (Expand Search), significant cause (Expand Search)
smaller decrease » small decrease (Expand Search), marked decrease (Expand Search), smaller areas (Expand Search)
degs increased » drugs increased (Expand Search), bems increased (Expand Search), days increased (Expand Search)
-
1
-
2
-
3
The profile of the 263 significant differentially expressed metabolites (DEMs).
Published 2021Subjects: -
4
-
5
Gene set enrichment analysis with identified DEG (|log2FC| ≥ 0.58, adj. p-value ≤ 0.05) of metabolite activated ILC2s compared to unstimulated ILC2s (red = upregulated pathways, blue = downregulated pathways, increasing circle size corresponds to increasing significance).
Published 2024“…<p>Gene set enrichment analysis with identified DEG (|log2FC| ≥ 0.58, adj. p-value ≤ 0.05) of metabolite activated ILC2s compared to unstimulated ILC2s (red = upregulated pathways, blue = downregulated pathways, increasing circle size corresponds to increasing significance).…”
-
6
-
7
-
8
-
9
-
10
Statins resulted in smaller neuronal soma size.
Published 2025“…Within control birds, the BrdU + /Hu+ neuron population was significantly smaller in soma size than the BrdU-/Hu+ older, heterogeneous population (A). …”
-
11
-
12
-
13
Gene set enrichment analysis with identified DEGs (|log2FC| ≥ 0.58, adj. p-value ≤ 0.05) of metabolite activated ILC2s pre-incubated with the selective DP<sub>2</sub> antagonist fevipiprant compared to metabolite activated ILC2s without fevipiprant stimulation (red = upregulated pathways, blue = downregulated pathways, increasing circle size corresponds to increasing significance).
Published 2024“…<p>Gene set enrichment analysis with identified DEGs (|log2FC| ≥ 0.58, adj. p-value ≤ 0.05) of metabolite activated ILC2s pre-incubated with the selective DP<sub>2</sub> antagonist fevipiprant compared to metabolite activated ILC2s without fevipiprant stimulation (red = upregulated pathways, blue = downregulated pathways, increasing circle size corresponds to increasing significance).…”
-
14
-
15
-
16
-
17
-
18
-
19
-
20